Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Clinical trial NCT03092544 · UNKNOWN
Trial details
- NCT number
- NCT03092544
- Sponsor
- Multiple Sclerosis Center of Northeastern New York
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2018-12-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.